Pliant Therapeutics

Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases. We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases. Pliant recognizes the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. Pliant is an equal opportunity employer and does not discriminate against any individual or potential candidate based on race, color, religion, sex, national origin, sexual preference or any other legally protected category. Pliant is located in South San Francisco, California, the birthplace of biotechnology. Proud to be a San Francisco Business Times Best Place to Work in 2023. Learn more about how we are breaking ground in the treatment of fibrotic diseases at www.PliantRx.com.

网站

https://www.pliantrx.com

Pliant Therapeutics的外部链接

所属行业

生物技术研究

规模

51-200 人

总部

South San Francisco，California

类型

上市公司

创立

2015

领域

fibrosis、integrins、muscle biology、oncology、Duchenne muscular dystrophy、Idiopathic pulmonary fibrosis、Primary sclerosing cholangitis、muscular dystrophy、Metabolic dysfunction-associated steatohepatitis和MASH